Chronic kidney disease, stage 3
Conditions
Interventions
This is a randomized, open-label, parallel-group clinical trial, with simple random allocation of participants to the intervention group and the control group. The randomization sequence was generated
due to the nature of the exercise intervention, blinding of participants and professionals responsible for the intervention was not possible. A total of 27 participants were randomized, with 46 alloca
Sponsors
Faculdade de medicina de botucatu - FMB/ Hospital das clinicas de Botucatu - HCFMB
Faculdade de medicina de botucatu - FMB/ Hospital das clinicas de Botucatu - HCFMB
Eligibility
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients aged 18 years or older;residing in Botucatu or neighboring cities within a 50-km radius;with a maximum age of 80 years;with the physical capacity to perform exercise.
Exclusion criteria
Exclusion criteria: Physical incapacity evaluated by a nephrologist;pregnant women;individuals with neoplasms of any kind.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected Outcome 1:It was expected that the implementation of a supervised 12-week aerobic exercise program would maintain or improve renal function in patients with stages 3–4 Chronic Kidney Disease (CKD) compared with the control group. The primary outcome was to be assessed by the estimated glomerular filtration rate (eGFR), calculated using the CKD-EPI equation, with the expectation of reducing the progression of renal function decline. Additionally, improvements were expected in laboratory markers of kidney function, particularly serum creatinine and blood urea levels, as well as favorable effects on body composition and functional capacity.;Observed Outcome 1:Participants who underwent the supervised aerobic exercise protocol demonstrated a significant improvement in renal function compared with the control group after the 12-week intervention. Significant reductions were observed in serum creatinine levels (3.5 ± 1.3 vs. 5.2 ± 2.0 mg/dL; p = 0.022) and blood urea levels (104.6 ± 25.4 vs. 137.7 ± 33.3 mg/dL; p = 0.013), along with a significant increase in estimated glomerular filtration rate (eGFR) (20.4 ± 6.5 vs. 13.6 ± 7.2 mL/min/1.73 m²; p = 0.027). No statistically significant differences were observed between the groups in body composition or functional capacity, although favorable trends were identified. Overall, the findings demonstrated that the supervised aerobic exercise protocol was safe, feasible, and effective in attenuating the progression of renal dysfunction in patients with advanced Chronic Kidney Disease (CKD). | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcomes are expected. | — |
Countries
BR
Contacts
Public ContactGabriel Rossi
Faculdade de medicina de botucatu - FMB/ Hospital das clinicas de Botucatu - HCFMB
Outcome results
None listed